Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid

Arch Dermatol. 2009 Jan;145(1):95-6. doi: 10.1001/archdermatol.2008.536.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Bone Density Conservation Agents / adverse effects*
  • Bone Diseases, Metabolic / drug therapy*
  • Bone Diseases, Metabolic / etiology
  • Diphosphonates / adverse effects*
  • Epidermolysis Bullosa Dystrophica / complications*
  • Humans
  • Hypocalcemia / chemically induced*
  • Imidazoles / adverse effects*
  • Male
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid